Goldman Sachs Names Ben Wallace as New Co-Head of Americas M&A Division

Goldman Sachs has appointed Ben Wallace as co-head of its Mergers and Acquisitions (M&A) division for the Americas, according to an internal memo. Wallace, who became a partner at the bank in 2022, will continue to serve as the global head of healthcare M&A, a role he has held since joining Goldman Sachs as managing director in 2018. In his expanded role, Wallace will collaborate with Avinash Mehrotra and Brian Haufrect to lead the regional M&A franchise. His responsibilities will include setting the strategic direction, driving business development, and ensuring smooth integration across the Americas M&A platform. This appointment underscores Goldman Sachs’ commitment to reinforcing its leadership in M&A advisory services across the region.

Ben Wallace began his Wall Street career at JPMorgan Chase in 2006, where he specialized in healthcare transactions. He was promoted to managing director in 2016. In 2018, Wallace joined Goldman Sachs as a managing director and was later named partner in 2022. Throughout his career, Wallace has advised on over $500 billion in announced transactions, including significant deals such as the $30 billion leveraged buyout of Medline Industries, the $16.4 billion sale of Varian to Siemens Healthineers, and the $8 billion sale of Signify Health to CVS Health.

Goldman Sachs, founded in 1869, is a leading global investment banking, securities, and investment management firm. The M&A division plays a crucial role in advising clients on mergers, acquisitions, divestitures, and other strategic transactions. The appointment of Wallace as co-head of Americas M&A aligns with the firm's strategy to strengthen its position in the M&A advisory market, particularly in the healthcare sector, which has seen increased activity due to factors like aging populations, technological innovation, and regulatory changes.

Wallace's promotion reflects Goldman Sachs' focus on sector-specific expertise, especially in healthcare, to drive high-value, complex transactions. His leadership is expected to enhance the firm's ability to capitalize on the growing healthcare M&A market, which is influenced by factors such as digital health advancements and consolidation trends. Additionally, his experience in cross-border transactions positions Goldman Sachs to navigate the complexities of international deal-making effectively.

This appointment is part of a series of leadership changes at Goldman Sachs aimed at bolstering its investment banking capabilities. In January 2025, the firm announced several leadership updates, including the appointment of Matt McClure, Anthony Gutman, and Kim Posnett as Global Co-heads of Investment Banking. These strategic moves underscore Goldman Sachs' commitment to maintaining its competitive edge in the global financial landscape.

In summary, Ben Wallace's elevation to co-head of Americas M&A signifies Goldman Sachs' strategic emphasis on the healthcare sector and its commitment to reinforcing its leadership in M&A advisory services across the region.